In France, on March 19, 2020, the Coalition for Epidemic Preparedness Innovations (CEPI) announced an investment of US$4.9 million in a consortium for the research of a vaccine against COVID-19 including the Institut Pasteur, Themis Bioscience (Vienna, Austria) and the University of Pittsburgh, bringing CEPI's total investment in the development of a vaccine against COVID-19 to US$29 million.
Huko Ufaransa tarehe 19 Machi 2020, Mseto wa Uvumbuzi wa Matayarisho ya Magonjwa ya Mlipuko (CEPI) ulitangaza uwekezaji wa dola milioni 4.9 katika ubia wa utafiti wa chanjo ya COVID-19 unaohusisha Taasisi ya Pasteur, Themis Biosciece (Vienna, Austria), na Chuo Kikuu cha Pittsburgh, na kuleta uwekezaji wa jumla wa CEPI wa maendeleo ya chanjo ya COVID-19 kuwa dola milioni 29.